Increase Team Productivity and Improve New Engagement Models
As in-person meetings become an option again, it can be tempting to return the focus to face-to-face HCP engagement. Proceed with caution. Going back to the status quo could be a mistake, considering that 87% of HCPs say they want all virtual or a mix of virtual and in-person meetings moving forward.1
New models include a blended or hybrid approach where field and medical teams spend more time engaging with HCPs remotely, resulting in more time spent on desktop devices than before. The hybrid model also requires digital reps who can quickly adapt to working both virtually and in-person and digital solutions that help ease this transition.
The newest Veeva CRM innovations support the agility needed for the life sciences industry to leverage engagement capabilities regardless of device. Here are the latest multichannel Veeva CRM innovations you can begin using now.
Reinventing the Desktop Experience for Hybrid Engagement
Optimized for remote and home office users, the new Veeva CRM Desktop Experience provides a more intuitive, modern, and tailored user interface with faster access to insights and better digital engagement capabilities. Teams stay productive regardless of the device they are using to access Veeva CRM.
Share Compliant Content from the Desktop
Considering the growing demands of digital engagement, having the right content readily available when engaging with HCPs is crucial. Commercial teams can now find, assemble, present, and share compliant Veeva CLM content via their desktop. Making it easier than ever for field teams when meeting with accounts face-to-face or remotely via Veeva CRM Engage Meeting, Zoom, or Microsoft Teams. Access the CLM media library with the Veeva CRM Desktop App directly from Calls in addition to Engage Meetings. Automatic tracking of all media activity on the call report provides a complete view of customer interactions.
Empower Medical and Events Teams
Veeva CRM Lightning Business Apps provide a personalized experience with functionality tailored for different roles and tasks. These role-based data visualization capabilities increase efficiency by giving business users insights to inform decisions better.
Veeva CRM now gives you access to two new Lightning Business Apps to use and customize based on business requirements. Each app is included with the Veeva CRM license and contains default configuration for Tabs, Views, and Page Layouts:
Event Coordinator Lightning Business App: Event planners and coordinators can quickly and easily access information such as events by type and format, used and remaining budgets, costs by expense type, and speaker cap reports
Field Medical Lightning Business App: Field medical users can quickly find and know more about their key stakeholders, capture deep medical insights, research the latest information in publications and clinical trials, and access other medical-related information.
Streamline Content Management
Simplify content management with multi-product support for Veeva CLM and Veeva Approved Email. With this release, content creators can avoid duplicating CLM and Approved Email content in Vault by assigning multiple products to their presentations (binders), slides, and email templates. Multi-product content generates one record per given product in Veeva CRM, resulting in a more streamlined content library that is easier to maintain.
Strengthen Account Plan Strategies
Understanding the relationships and structures of complex accounts is vital to effective key account management (KAM) strategies. The Stakeholder Navigator visualizes the structure and relationships between accounts within the same organization or hierarchy, making it simple to manage key people or create and execute successful account management strategies.
Are you up to date with the latest Veeva CRM innovations, best practices, and upcoming events? Visit the Veeva CRM online help page for more detailed information, or contact your account representative.
___________________________________ 1Accenture: Is COVID-19 Altering how pharma engages with HCPS?